3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Keratosis, Actinic
9
Uterine Cervical Dysplasia
3
Melanoma
3
Breast Neoplasms
3
Squamous Intraepithelial Lesions
2
Papillomavirus Infections
2
HIV Infections
2
Condylomata Acuminata
2
Vulvar Neoplasms
1
Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)
1
Virus Diseases
1
Squamous Cell Carcinoma of Head and Neck
1
Sexually Transmitted Diseases
1
Pigmentation Disorders
1
Neoplasms
1
Keratosis
1
Hemangioma, Capillary
1
Glioblastoma
1
Breast Neoplasms, Male
1
Anus Neoplasms
1
Acquired Immunodeficiency Syndrome
1
Interventions
Paclitaxel
19
pembrolizumab
16
Carboplatin
12
Bevacizumab
8
lenvatinib
6
rucaparib
5
Nivolumab
5
Megestrol Acetate
5
Radiation
4
Indocyanine Green
4
Gemcitabine
4
Cisplatin
4
tisotumab vedotin
3
temsirolimus
3
Sirolimus
3
Sentinel Lymph Node Biopsy
3
Magnetic Resonance Spectroscopy
3
Doxorubicin
3
olaparib
2
niraparib
2
ixabepilone
2
iso-sulfan blue
2
irosustat
2
epacadostat
2
durvalumab
2
copanlisib
2
Trastuzumab
2
Taxes
2
Specimen Handling
2
Radiotherapy, Intensity-Modulated
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Endometrial Neoplasms
×
Imiquimod
×
Clear all
No trials found.